Artículos por temáticas

Effect of Botulinum Toxin on Sensori-Motor Integration in Movement Disorders: A Scoping Review

Das A, Jog M.

Toxins (Basel). 2025 Aug 16;17(8):416. doi: 10.3390/toxins17080416.

The Use of Conversational Repairs in Interactions Involving People With Parkinson's Disease: A Large Corpus Comparison Study

Tetzloff KA, Barrett TS, Liss JM, Borrie SA.

J Speech Lang Hear Res. 2025 Jul 8;68(7):3090-3106. doi: 10.1044/2025_JSLHR-24-00802. Epub 2025 Jun 4.

Subtle concentration changes in zinc hold the key to fibrillation of α-synuclein: an updated insight on the micronutrient's role in prevention of neurodegenerative disorders

Banik SP, Bagchi D, Banerjee P, Chakraborty S, Bagchi M, Bose C, De D, Saha S, Chakraborty S.

Front Mol Biosci. 2025 Jul 10;12:1603364. doi: 10.3389/fmolb.2025.1603364. eCollection 2025.

Recent Advances in Amyloids Structural Studies and Thin Film Applications

Pechkova E, Fiordoro S, Izzotti A, Riekel C.

Molecules. 2025 Jul 9;30(14):2908. doi: 10.3390/molecules30142908.

Healthcare Service Utilisation of People Living With Non-Alzheimer's Dementia: A Systematic Review

Tjin A, Thang LL, Sondh HK, Stewart R.

J Geriatr Psychiatry Neurol. 2025 Aug 28:8919887251371725. doi: 10.1177/08919887251371725. Online ahead of print.

Evaluation of Mortality in Users of Pimavanserin Compared with Other Atypical Antipsychotics in Patients with Parkinson's Disease Psychosis: An Update

Rao S, McQuay LJ, Forns J, MacKay R, Danysh HE, Doshi D, Abler V, Anthony MS, Layton JB.

Drug Saf. 2025 Aug;48(8):893-907. doi: 10.1007/s40264-025-01543-8. Epub 2025 Apr 9.

Progranulin Mutation Manifesting as Parkinson Disease: A Case Series from the PADUA-CESNE Cohort

Bonato G, Campagnolo M, Emmi A, Misenti V, Carrer T, Fogliano C, Salviati L, Carecchio M, Antonini A.

Mov Disord Clin Pract. 2025 Jul;12(7):998-1002. doi: 10.1002/mdc3.70064. Epub 2025 Apr 4.

[From diagnosis to rehabilitation in Parkinson's disease: Are we arriving too late?]

Candoni G.

Rehabilitacion (Madr). 2025 Jul-Sep;59(3):100914. doi: 10.1016/j.rh.2025.100914. Epub 2025 May 15.

Left Cerebellar Stroke in a Patient With Parkinson's Disease Complicated With Prolonged Position-Related Compression Syndrome: A Case Report

Shkvarok-Lisovenko AK, Korost Y, Sokolova LP, Ilina OA, Lisovenko Y.

Cureus. 2025 Jul 26;17(7):e88798. doi: 10.7759/cureus.88798. eCollection 2025 Jul.

Adult-Onset BPAN: An Atypical Presentation Mimicking Early-Onset Parkinson's Disease

Monje MHG, Vittal P, Keller Sarmiento IJ, Kinsley L, Krainc D, Mencacci NE.

Mov Disord Clin Pract. 2025 Aug 23. doi: 10.1002/mdc3.70313. Online ahead of print.

A Case of Successful Use of Higher Dose Dupilumab in the Treatment of Pemphigoid Nodularis Combined With Parkinson's Disease

Gao Z, Liang Q, Chen S, Ruan J, Zhu K, Cheng H.

Int J Dermatol. 2025 Aug;64(8):1501-1503. doi: 10.1111/ijd.17685. Epub 2025 Feb 11.

Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies

Ferreira JJ, Lee JY, Ma HI, Jeon B, Poewe W, Antonini A, Stocchi F, Rodrigues DM, Fonseca MM, Castilla-Fernández G, Holenz J, Rocha JF, Rascol O; ADOPTION study investigators.

J Neurol. 2025 Aug 1;272(8):549. doi: 10.1007/s00415-025-13122-z.

Reply to: "Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example"

Weintraub D, Brumm MC, Kurth R, York MK.

Mov Disord. 2025 Jul;40(7):1444-1445. doi: 10.1002/mds.30247. Epub 2025 May 29.

Switching Gears: From Intrajejunal Levodopa to Subcutaneous Foslevodopa

B Mohammed W, McGuckin A, Poon YY, Fasano A.

Mov Disord Clin Pract. 2025 Aug 26. doi: 10.1002/mdc3.70327. Online ahead of print.

Think Beyond the Obvious: Atypical Pulmonary Embolism Presentation in a Parkinson's Disease Patient

Rehman A, Chishti SZ, Bibi F.

Cureus. 2025 Jul 22;17(7):e88520. doi: 10.7759/cureus.88520. eCollection 2025 Jul.